Guideline References

Return to list of National Guidelines

Ref. 1

Appraisal of guidelines for research and evaluation. www.agreetrust.org

Ref. 2 (Austria)

Dimai HP, Pietschmann P, Resch H, Leb G, Klaushofer K. Leitfaden zur medikamentösen Therapie der postmenopausalen Osteoporose. Wien Med Wschr 2002; 152: 596-612.

Ref. 3 (Canada)

2010 Clinical Practice Guidelines for the Diagnosis and Management of Osteoporosis in Canada. A. Papaioannou, S. Morin, A.M. Cheung, S. Atkinson, J. P. Brown, S. Feldman,
D.A. Hanley, A. Hodsman, S. A. Jamal, R. G. Josse, S. M. Kaiser, B. Kvern, K.Siminoski,
W.D. Leslie; for the Scientific Advisory Council of Osteoporosis Canada
http://www.osteoporosis.ca/multimedia/pdf/Osteoporosis_Guidelines_2010_Background_And_Technical_Report.pdf 

Ref. 4 (Denmark)

National Osteoporosis Guidelines by the Danish Endocrine Society co-endorsed by the Danish Bone Society and the National Board of Health, as follows:
Postmenopausal Women: http://www.endocrinology.dk/index.php/3-calcium-og-knoglemetaboliske-sygdomme/3-osteoporose
Men: http://www.endocrinology.dk/index.php/3-calcium-og-knoglemetaboliske-sygdomme/nbv-endokrinologi-behandling-af-mandlig-osteoporose-sekundaer-osteoporose-mandlig-hypogonadisme-d-vitamin
Glucocorticoid-induced osteoporosis: http://www.endocrinology.dk/index.php/nbvhovedmenu/3-calcium-og-knoglemetaboliske-sygdomme/4-glukokortikoid-induceret-osteoporose
 

Ref. 5 (France)

Actualisation 2012 des recommandations françaises du traitement médicamenteux de l'ostéoporose post-ménopausique
http://www.grio.org/documents/rcd-9-1352803804.pdf

Ref. 6 (Germany)

DVO-Leitlinie 2009 zur Prophylaxe, Diagnostik und Therapie der Osteoporose, Langfassung Dachverband Osteologie e.V. (DVO)
www.lutherhaus.de/osteo/leitlinien-dvo
DVO-Leitlinie-2009_Langfassung_Version_06-03-09.pdf

Dachverband Osteologie (2011) DVO Guideline 2009 for prevention, diagnosis and therapy of osteoporosis in adults. Osteologie 20: 55–74

2014 DVO Guidelines for the prevention, diagnosis and therapy of osteoporosis in postmenopausal women and men aged 60 and over.
www.dv-osteologie.org/dvo_leitlinien/osteoporose-leitlinie-2014

Ref. 7 (Greece)

2011 Guidelines for the Diagnosis and Treatment of Osteoporosis in Greece.
J Musculoskelet Neuronal Interact. 2012 Mar;12(1):38-42.
Makras P1, Vaiopoulos G, Lyritis GP; Greek National Medicine Agency.
http://www.ismni.org/jmni/pdf/47/06MAKRAS.pdf

Cost-effective osteoporosis treatment thresholds in Greece
Makras, P., Athanasakis, K., Boubouchairopoulou, N. et al. Osteoporos Int (2015) 26: 1949. doi:10.1007/s00198-015-3055-8

Ref. 8 (Italy)

Guidelines for the diagnosis, prevention and management of osteoporosis 2016
Reumatismo: Official Journal of the Italian Soc. for Rheumatology. M. Rossini, S. Adami, F. Bertoldo, D. Diacinti, et al. (SIOMMS), Vol 68, No 1 (2016)
http://dx.doi.org/10.4081/reumatismo.2016.870 

Ref. 9 (Lebanon)

First Update of the Lebanese Guidelines for Osteoporosis Assessment and Treatment (2007)
Ghada El-Hajj Fuleihan, MD, MPH; Rafic Baddoura, MD, MPH; Hassane Awada, MD; Asma Arabi, MD, MS and Jad Okais, MD, J Med Liban 2007; 55(4):176-191
Download PDF (623.4 KB)
Lebanese guidelines on osteoporosis assessment and treatment. Journal of Clinical Densitometry (2004); El-Hajj Fuleihan G, Baddoura R, Awada H, Okais J, Risk P, McClung M.
Download PDF (623.4 KB)

Ref. 10 (Netherlands)

Richtlijn Osteoporose en fractuurpreventie derde herziening (2011), Nederlandse Vereniging voor Reumatologie
https://www.nvr.nl/wp-content/uploads/2014/11/CBO-richtlijn-osteoporose-en-fractuurpreventie-2011.pdf

Ref. 11 (Spain)

Updated 3rd version (2011):
Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de Investigación Ósea y del Metabolismo Mineral (3.ª versión actualizada 2014)
Clinical practice guidelines for postmenopausal, glucocorticoid-induced and male osteoporosis. Spanish Society for Research on Bone and Mineral Metabolism (3rd updated version 2014)
http://www.revclinesp.es/es/linkresolver/guias-practica-clinica-osteoporosis-posmenopausica/S0014256515002192/

Guías de práctica clínica en la osteoporosis posmenopáusica, glucocorticoidea y del varón. Sociedad Española de Investigación Ósea y del Metabolismo Mineral (SEIOMM). 2008
J. González Macías, N. Guañabens Gay, C. Gómez Alonso, L. del Río Barquero, M. Muñoz Torres, M. Delgado, L. Pérez Edo, J. Bernardino Díaz López, E. Jódar Gimeno y F. Hawkins Carranza (Comité de Redacción, en representación del Comité de Expertos de la SEIOMM para la elaboración de las Guías). Download from  www.seiomm.org

Ref. 12 (UK)

NOGG Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of
50 years in the UK,  Updated March 2014
Pocket Guide for HCPs: http://www.shef.ac.uk/NOGG/NOGG_Pocket_Guide_for_Healthcare_Professionals.pdf
Executive Summary: http://www.shef.ac.uk/NOGG/NOGG_Executive_Summary.pdf
Info for patients: http://www.shef.ac.uk/NOGG/NOGG_Information_for_patients.pdf

Compston JE, Cooper A, Cooper C et al (2009) Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from
the age of 50 years in the UK. Maturitas 62: 105–8

National Institute for Health and Clinical Excellence (2011) Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women. Technology appraisal TA161. http://egap.evidence.nhs.uk/TA161 Accessed 24 May 2011

National Institute for Health and Clinical Excellence (2011) Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in
postmenopausal women. Technology appraisal TA160. http://guidance.nice.org.uk/TA160 Accessed 24 May 2011

National Institute for Health and Clinical Excellence (2010) Denosumab for the prevention of osteoporotic fractures in postmenopausal women. Technology appraisal 204 http://guidance.nice.org.uk/TA204  Accessed 24 May 2011

Ref. 13 (UK)

Glucocorticoid-induced osteoporosis. Guidelines on prevention and treatment. Bone and Tooth Society of Great Britain, National Osteoporosis Society and Royal College of Physicians. Royal College of Physicians, London UK. Website: www.rcplondon.ac.uk

Ref. 14 (Scotland)

Scottish Intercollegiate Guidelines Network (SIGN 111), Management of Hip Fracture in Older People, June 2009
http://www.sign.ac.uk/pdf/sign111.pdf 

Ref. 15 (Scotland)

Scottish Intercollegiate Guidelines Network (SIGN 142), Management of osteoporosis and the prevention
of fragility fractures, March 2015
http://www.sign.ac.uk/pdf/SIGN142.pdf 

Ref. 16 (USA)

The National Osteoporosis Foundation (NOF) Clinician's Guide to prevention and treatment of osteoporosis 2014.  Osteoporos Int. 2014; 25(10): 2359–2381. doi:  10.1007/s00198-014-2794-2 http://link.springer.com/article/10.1007%2Fs00198-014-2794-2 

Ref. 17 (USA)

American Association Of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis -2016
https://www.aace.com/files/final-appendix-sept-7.pdf

Ref. 18 (USA)

Screening for osteoporosis: recommendation statement of the U.S. Preventive Services Task Force. Updated in 2010. Annals of Internal Medicine 2011 Jan 18. [Epub ahead of print]). Website:  http://www.uspreventiveservicestaskforce.org/uspstf10/osteoporosis/osteors.htm

Ref. 19 (USA)

Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society
https://www.menopause.org/docs/default-document-library/psosteo10.pdf?sfvrsn=2 

Ref. 20 (USA)

Grossman, J. M., Gordon, R., Ranganath, V. K., Deal, C., Caplan, L., Chen, W., Curtis, J. R., Furst, D. E., McMahon, M., Patkar, N. M., Volkmann, E. and Saag, K. G. (2010), American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res, 62: 1515–1526. doi: 0.1002/acr.20295

Ref. 21 (Middle East and North Africa)

Middle East and North Africa Consensus on Osteoporosis

G.MAALOUF1, M-H. GANNAGE-YARED1, J.EZZEDINE1, B.LARIJANI2 , S. BADAWI3, A. RACHED3, L.ZAKRAOUI4, B. MASRI5, E.AZAR5, E.SABA6, R.NAMMARI6, G.ADIB7, H. ABOU SAMRA7, Z. ALRAWI8, S. SALMAN8, K. EL MUNTASSER9, R.TARSEEN9, W.EL KHAROUSSI10, M.AL-LAMKI10, A.N. ALOTHMAN11, N. ALMARZOOK11, M.EL DESSOUKI12, R.SULAIMANI12, J. SALEH13, A.R. SUHAILI14, A. KHAN15, P. DELMAS16, E.SEEMAN17.

1 Lebanese Osteoporosis Prevention Society;2 Endocrinology & Metabolism Center. – Shariati Hospital – Iran;3 Egyptian Osteoporosis Prevention Society;4 Tunisian Osteoporosis Prevention Society;5 Jordanian Osteoporosis Prevention Society;6 Palestinian Osteoporosis Prevention Society ;7 Syrian Council of Osteoporosis;8 Iraqi Osteoporosis Society;9 Libyan Osteoporosis Society ;10 Oman Osteoporosis Society;11 Kuwaiti Osteoporosis Society ;12 Saudi Osteoporosis Club;13 Bahrain Osteoporosis Society ;14 Gulf Osteoporosis Society ;15 Division of Endocrinology and Geriatrics – McMaster University- Canada; 16 President of IOF-Hopital Edouard Herriot-France;17 Endocrinology, Austin and Repatriation Medical Centre, University of Melbourne, Australia

Download PDF (PDF, 140.7 KB)
Published in Published in J Musculoskeletal Neuronal Interact 2007; 7(2):131-143

Ref. 22 (Chile)

Guías de Diagnóstico, Prevención y Tratamiento de Osteoporosis, published by the Sociedad Chilena de Reumatologia and the
Sociedad Chilena de Osteologia y Metablismo Mineral, 2006
Download guidelines (PDF, 572 KB)

Ref. 23 (Argentina)

Guías 2012 para el diagnóstico, la prevención y el tratamiento de la osteoporosis
L. Schurman, A.bagur, H-C.. Hermberg, O.D.. Messina, A.L. Negri, A.Sánchez, C.González, M.Diehl, P.La Rey, J.Gamba, J.Chiarpenello, M.D. Moggia, S.Mastaglia
MEDICINA (Buenos Aires) 2013; 73: 55-74, ISSN 0025-7680

Consenso de la Sociedad Argentina de Osteoporosis y la Asociación Argentina de Osteologia y Metabolismo Mineral.
Download guidelines (PDF)

Ref. 24 (Poland)

Polish guidelines for the diagnosis and management of osteoporosis: a review of 2013 update (PDF in English)
Piotr Głuszko, Roman S. Lorenc, Elżbieta Karczmarewicz,Waldemar Misiorowski, Maciej Jaworski. Pol Arch Med Wewn. 2014;124 (5): 255-263

Original guidance in Polish: Lorenc R, Gluszko P, Karczmarewicz E et al. Zalecenia postępowania diagnostycznego i leczniczego w osteoporozie. Aktualizacja 2013. Medycyna Praktyczna 2013.wyd.spec 1/2013

Ref. 25 (Malaysia)

Clinical Guidance on Management of Osteoporosis 2012
Published by the Malaysian Osteoporosis Society (Persatuan Osteoporosis Malaysia). Endorsed by the Malaysian Health Technology Assessment Section (MaHTAS); Medical Development Division, Ministry of Health Malaysia. Download PDF
Also available on the following websites www.osteoporosis.my ; www.moh.gov.my ; www.acadmed.org.my; www.msr.my

Ref. 26 (Europe)

European Guidance for the Diagnosis and Management of Osteoporosis in Postmenopausal Women
Kanis, J.A., McCloskey, E.V., Johansson, H. et al. Osteoporos Int (2013) 24: 23
doi:10.1007/s00198-012-2074-y
https://link.springer.com/article/10.1007/s00198-012-2074-y 
 

Ref. 27 (China)

Guidelines for Osteoporosis, Chinese Journal of Osteoporosis: http://yunpan.cn/QX3JYpTKPiDuZ

Ref. 28 (China)

Guidelines for primary osteoporosis diagnosis and management, Osteoporosis and Bone Mineral Society of the Chinese Medical Association

Ref. 29 (China)

2008: Guidelines for osteoporosis fracture management, Orthopedic Society of Chinese Medical Association. Chin J Otthop, 2008; 28(10):875-878

Ref. 30

to follow

Ref. 31 (Czech Republic)

Rosa J, Šenk F, Palička V; with cooperation of Blahoš J, Bayer M., Broulík P, Horák P, Kasalický P, Kučerová I, Kuba V, Kutílek Š, Pikner R, Vyskočil V.  Diagnosis and treatment of postmenopausal osteoporosis. Statement of the Czech Society for Metabolic Bone Diseases
Osteol Bull 2015; 20/4/:150-168 (in Czech)

Rosa J, with cooperation of Blahoš J, Bayer M., Broulík P, Horák P, Kasalický P, Kučerová I, Kuba V, Kutílek Š, Palička V, Pikner R, Šenk F, Vyskočil V.
Osteoporosis in males. Statement of the Czech Society for Metabolic Bone Diseases
Osteol Bull 2016; 21/2/:42-48 (in Czech)

Ref. 32 (Estonia)

Available on website www.osteoporoos.ee/arstidele.html

Ref. 33

 

Ref. 34 (Hungary)

National Guidelines of the Hungarian Society for Osteoporosis and Osteoarthrology (HSOO).
Calcium and Bone, 2006, Vol 8, pp.116-155

Ref. 35

Ref. 36 (Lithuania)

Alekna V, Tamulaitienė M, Krasauskienė A. Osteoporozės diagnostikos ir gydymo metodika. Nauja 2011 metų redakcija (Guideline for osteoporosis diagnosis and treatment (updated version 2011- In Lithuanian).
Gerontologija. 2011;12(2):110-130. http://www.gerontologija.lt/files/edit_files//File/pdf/2011/nr_2/2011_110_130.pdf

Ref. 37 (Portugal)

Recommendations for the Diagnosis and treatment of Osteoporosis (OP), prepared by the Portuguese
Society of Rheumatology (SPR) and the Portuguese Society of Metabolic Bone Diseases (SPODOM). 2007
http://www.spreumatologia.pt/files/guideline/18_recomenda_es_para_o_diagn_stico_e_terap_utica_da_osteoporose_file.pdf
 

Ref. 38 (Slovenia)

Smernice za odkrivanje in zdravljenje osteoporoze /Guidelines for the detection and treatment of osteoporosis (2013)
Tomaž Kocjan, Janez Preželj, Marija Pfeifer, Mojca Jensterle Sever, Miro Čokolič, Andrej Zavratnik
Zdrav Vestn 2013; 82: 207–17
http://vestnik.szd.si/index.php/ZdravVest/article/view/635

Ref. 39 (Sweden)

National Guidelines for Musculoskeletal Diseases (2015)
http://www.socialstyrelsen.se/nationellariktlinjerforrorelseorganenssjukdomar 

Socialstyrelsens riktlinjer för vård och behandling av höftfraktur (National guidelines for management of hip fractures) HBWH 2003
ISBN: 91-7201-758-9; Treatment recommendations from the MPA 2007
www.lakemedelsverket.se/Tpl/RecommendationsPage.aspx?id=2605

Ref. 40

Consenso Iberomericano de Osteoporosis SIBOMM 2009 (PDF, 315.5 KB)
 
Osteoporosis: Prevención, Diagnóstico y Tratamiento
Sociedad Iberoamericana de Osteología y Metabolismo Mineral
(SIBOMM). English version (PDF, 377.5 KB)

Ref. 41 (Singapore)

Singapore Ministry of Health: Clinical Practice Guidelines for Osteoporosis 3/2008
Published January 2009. Available on the MOH website: http://www.moh.gov.sg/cpg

Ref. 42 (Asia)

Guidelines for diagnosing, prevention and treatment of osteoporosis in Asia
E. M. C. LAU , P. SAMBROOK , E. SEEMAN, K. H. LEONG, P. C. LEUNG and P. DELMAS
Published in APLAR Journal of Rheumatology, Vol. 9, Issue 1, p. 24-26, May 2006:
PDF available at http://www3.interscience.wiley.com/journal/120092309/issue

Ref. 43 (Iran)

Physician Guidelines for Prevention and Treatment of Osteoporosis
(2008) published by the EMRC. Available in Farsi on http://emrc.tums.ac.ir/emrcfa/default.aspx

Ref. 44 (Australia)

Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. February 2010. Approved by NHMRC - National Health and Medical Research Council. Published by The Royal Australian College of General Practitioners
http://www.racgp.org.au/Content/NavigationMenu/ClinicalResources/RACGPGuidelines/osteoporosis1/RACGP_Osteo_guideline.pdf
ISBN 978-0-86906-306-4

Ref. 45 (Lebanon)

Guidelines for fragility fracture in Lebanon
Maalouf G, Bachour F, Issa M, Yazbeck P, Maalouf N, Daher C, Yaghi Y, Eid R. J Med Liban. 2012 Jul-Sep;60(3):153-8
Contact: Musculoskeletal Dpt., BUMC (Bellevue University Medical Center), Mansourieh-Lebanon. gmaalouf@bmchcs.com
Endorsed by Lebanese Ministry of Public Health

Ref. 46 (Japan)

Japanese 2011 guidelines for prevention and treatment of osteoporosis.
Executive summary (in English)
Hajime Orimo, Toshitaka Nakamura, Takayuki Hosoi, Masayuki Iki, Kazuhiro Uenishi, Naoto Endo, Hiroaki Ohta, Masataka Shiraki, Toshitsugu Sugimoto, Takao Suzuki, Satoshi Soen, Yoshiki Nishizawa, Hiroshi Hagino, Masao Fukunaga, Saeko Fujiwar
Arch Osteoporos (2012) 7:3-20
http://link.springer.com/article/10.1007/s11657-012-0109-9

Ref. 47 (Japan)

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update
Suzuki, Y., Nawata, H., Soen, S. et al. J Bone Miner Metab (2014) 32: 337. doi:10.1007/s00774-014-0586-6
http://link.springer.com/article/10.1007%2Fs00774-004-0596-x 

Ref. 48 (South Africa)

South African Clinical Guideline for the Diagnosis and Management of Osteoporosis: 2010 (released January 2011). Stephen Hough, Brynne H. Ascott-Evans, Susan L. Brown, Bilkish Cassim, Tobie J. de Villiers, Stan Lipschitz, John M. Pettifor and Ernst W.W. Sonnendecker. For the National Osteoporosis Foundation of South Africa (NOFSA).  A summary of the guidelines was published in Journal of Endocrinology, Metabolism and Diabetes South Africa (JEMDSA). Download NOFSA Guidelines referenced (PDF, 1.46 MB)

Ref. 49 (Taiwan)

Taiwanese Guidelines for the Prevention and Treatment of Osteoporosis. Published by theTaiwanese Osteoporosis Association. Sept. 4, 2011 - Sept. 3, 2013
Download Guidelines in English translation (PDF, 729 KB)

Ref. 50 (Slovakia)

Slovak Republic Ministry of Health Guidelines for the Diagnosis and Treatment of Patients with Osteoporotic Fractures
Ministry of Health Bulletin, February 4, 2011, No. 59, Part 1-3
English Translation (PDF, 97 KB)

(Slovak Republic Ministry of Health Guidelines for the Diagnosis of Glucocorticoid-induced Osteoporosis
Ministry of Health Bulletin, November 13, 2009, No. 57, Part 51-53
English Translation (PDF, 52 KB)

Slovak Republic Ministry of Health Guidelines for the Diagnosis and Treatment of Osteoporosis Ministry of Health Bulletin, March 1, 2006, No. 54, Part 9-16
English Translation (PDF, 729 KB))

Ref 51 (Norway)

Faglige retningslinjer for forebygging og behandling av osteoporose og osteoporotiske brudd
12/2005
IS-1322 ISBN978-82-8081-076-5
Utgitt av: Sosial- og helsedirektoratet
Kontakt: Avdeling for primærhelsetjenester
www.shdir.no

Ref 52 (Brazil)

Guidelines for the prevention and treatment of glucorticoid-induced osteoporosis
Rosa Maria Rodrigues Pereira, Jozélio Freire de Carvalho, Ana Patrícia Paula, Cristiano Zerbini et al. Rev Braz Reumatol. 2012; 52(4):569-593
English PDF

Ref 53 (Bulgaria)

Recommendations for good clinical practice in osteoporosis of Bulgarian Society of Endocrinology and Bulgarian Society of Rheumatology. Borissova A-M, Zacharieva S, Boyanov M, Kovacheva R, Rashkov R, Kolarov Z, Popivanov P, Shinkov A, Petranova T.. Ed. Prof. Anna-Maria Borissova. SD Simolini 94, Sofia, 2013. English Abstract PDF

Ref 54 (Bulgaria)

Recommendations for the diagnosis, prevention and treatment of vitamin D insufficiency and deficiency of Bulgarian Society of Endocrinology, Bulgarian Society of Rheumatology, Bulgarian Pediatric Association, Bulgarian Society of Clinical Laboratory. Borissova A-M, Boyanov M, Kolarov Z, Popivanov P, Shinkov A, Stoilov R, Svinarov D. Petranova T, Pilossof V. Ed. Prof. Anna-Maria Borissova. SD Simolini 94, Sofia, 2013. English Abstract PDF

Ref 55 (Finland)

Osteoporosis Guidelines for Professionals (2014) http://www.kaypahoito.fi/web/kh/suositukset/suositus?id=hoi24065

Osteoporosis guidelines for patients (2015)  http://www.kaypahoito.fi/web/kh/potilaalle/suositus?id=khp00023&suositusid=hoi24065

Specific guidelines for hip fracture, wrist fracture & lower leg fractures (professionals)
Specific guidelines for hip fracture, wrist fracture & lower leg fractures (patients)

Ref 56 (Latvia)

Lejnieks Aivars, Aizstrauta Tamāra, Ādamsone Ināra, Matule Dace, Rasa Ingvars,
Rumba Ingrīda, Platkājis Ardis, Vestermanis Viktors. 
Osteoporozes diagnostikas, profilakses un ārstēšanas vadlīnijas. Rīga, 2005.

REF.  Lejnieks A., Aizstrauta T., Matule D., Rasa I., Rumba I, Platkajis A., Vestermanis V. 
National Guidelines for the Diagnostics, Prevention and Treatment of Osteoporosis. Baltic Endocrinology. 2006; 2, 1: 41 – 51.

Ādamsone Ināra, Daukste Ilze, Dzīvīte Iveta, Lejnieks Aivars, Platkājis Ardis, Rasa Ingvars. 
Osteodensitometrijas mērījumu veikšanas rekomendācijas Latvijā. Rīga, 2007.

REF.  Adamsone, I., Daukste, I., Dzivite, I., Lejnieks, A., Platkajis, A., Rasa, I.
Recommendations for osteodensitometry testing in Latvia. Baltic Endocrinology.
2008; 4,1: 25 – 37.

Rasa Ingvars. Eiropas Osteoporozes un osteoartrīta klīnisko un ekonomisko aspektu
novērtēšanas biedrības (ESCEO) ieteikumi osteoporozes diagnostikā un ārstēšanā
sievietēm menopauzē. Rīga, 2008.

Rasa  Ingvars (red.),  Ādamsone Ināra, Daukste Ilze, Pavliņa Inese, Platkājis Ardis, Vētra Anita, Zelča Signe. Osteoporozes klīniskās vadlīnijas. Rīga: Latvijas Osteoporozes un kaulu metabolo slimību asociācija, 2011.

Rasa  Ingvars (red.), Ādamsone Ināra, Daukste Ilze, Pavliņa Inese, Platkājis Ardis, Vētra Anita, Zelča Signe. Osteoporozes klīniskās vadlīnijas. Rīga: Latvijas Osteoporozes un kaulu metabolo slimību asociācija, 2012 (updated).

http://www.vmnvd.gov.lv/lv/420-kliniskas-vadlinijas/klinisko-vadliniju-datu-baze/registretas-2012gada/osteoporozes-klnisks-vadlnijas

Rasa Ingvars (red.), Ādamsone Ināra, Daukste Ilze, Pavliņa Inese, Platkājis Ardis, Vētra Anita, Zelča Signe. Osteoporosis clinical guidelines ( in engl.) Rīga: Latvijas Osteoporozes
un kaulu metabolo slimību asociācija, 2013/2014 (project).

Ref 57 (India)

Clinical practice Guidelines on postmenopausal osteoporosis: An executive summary and recommendations. Indian Menopause Society
Chair: Meeta Co-Chairs:Harinarayan C.V, Marwah Raman,Kalra Sanjay,Sahay Rakesh, Babhulkar Sushrut  
Clinical practice guidelines on menopause: *An executive summary and recommendations. Meeta, Digumarti L, Agarwal N, Vaze N, Shah R, Malik S. J Mid-life Health [serial online] 2013 [cited 2013 Sep 16];4:77-106.
Available from: http://www.jmidlifehealth.org/text.asp?2013/4/2/77/115290

Ref 58 (Hong Kong, China)

Ip, TP, Cheung, SK, Cheung, TC, Choi, TC, Chow, SL, Ho, YY, Kan, SY, Kung, WC, Lee, KK, Leung, KL, Leung, YY, Lo, ST, Sy, CT & Wong, YW 2013, ‘OSHK Task Group for Formulation of 2013 OSHK Guideline for Clinical Management of Postmenopausal Osteoporosis in Hong Kong’, Hong Kong Med J, vol. 19, no. 2, pp. 1-40  http://www.hkmj.org/supplements/article_pdfs/hkm1304sp2p6.pdf

Ref 59 (India)

Krishnamurthy, V, Sharma, A, Aggarwal, A, Kumar, U, Amin, S, Rao, UR, Narsimulu, G, Handa, R, Mithal, A & Joshi, S 2011, ‘Indian Rheumatology Association Guidelines for Management of Glucocorticoid-induced Osteoporosis’, Indian J Rheumatol, vol. 6, no. 2, pp. 68-75.

Ref 60 (China)

Chinese Medical Association. Osteoporosis Treatment Guidelines, 2006, with an update in 2011 
http://www.haodf.com/zhuanjiaguandian/liaodefa_583581080.htm

Ref 61 (Philippines)

Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines International Journal of Rheumatic Diseases. Vol 14, Issue 3, Aug. 2011, p. 223–238, J. Li-Yu, E. C. Perez, A. Canete, L. Bonificio, L. Q. Llamado, R. Martinez, A. Lanzon and M. Sison, on behalf of the Osteoporosis Society of the Philippines Foundation, Inc. (OSPFI) and Philippine Orthopedic Association (POA) Clinical Practice Guidelines Task Force Committee on Osteoporosis. http://onlinelibrary.wiley.com/doi/10.1111/j.1756-185X.2011.01626.x/abstract

Ref 62 (Vietnam)

Diagnosis and Treatment of Osteoporosis. Guidelines for Diagnosis and Treatments of Common Rheumatic Diseases. (2012) Hanoi, Viet Nam Education Publishing House: 247-258.

Ref 63 (Thailand)

Royal College of Orthopaedic Surgeons of Thailand and Thai Osteoporosis Foundation: Clinical practice guideline for osteoporosis 2010.

Ref 64 (Brazil)

Consensus: Recommendations of the Brazilian Society of Endocrinology and Metabology (SBEM) for the diagnosis and treatment of hypovitaminosis D
Arq Bras Endocrinol Metab. 2014;58/5  Download Guidelines

Ref 65 (China)

The Application Guideline for Vitamin D and Bone Health in Chinese Adult (2014 Standard Edition). Chin J Osteoporos, September 2014, Vol 20, No. 9. Published online www.wanfangdate.com.cn doi:10.3969/j. issn. 1006-7108. 2014. 09. 000.

Ref. 66 (Lebanon)
Lebanese FRAX-based Osteoporosis Guidelines (2013) Executive Summary. Reference: Chakhtoura M, Leslie WD, McClung M, Cheung AM, El-Hajj Fuleihan G. FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model, Osteoporosis International 2016 In Press

Ref. 67 (Morocco)

F.Ezzahra Abourazzak, H. Khazzani, S.Mansouri, S. Ali Ou Alla, F. Allali, A. El Maghraoui, S. Larhrissi, R. Niamane, W. Rachidi, L. Ichchou.
Rev Mar Rhum 2016; 35:3-15
 

Ref 68 (Belgium)

Please see complete list of consensus, guidelines and respective references on the Belgium Bone Club website: http://www.bbcbonehealth.org/consensus-paper

Ref 69 (Switzerland)

Osteoporosis Recommendations from the Swiss Association against Osteoporosis (SVGO/ASCO) in 2015
http://www.svgo.ch/content/documents/2015/SVGO%20Empfehlungen%202015.pdf
References: http://www.svgo.ch/content/documents/2015/SVGO_Empfehlungen2015_Literatur.pdf

Ref 70(Jordan)
PDF icon Jordanian Osteoporosis Prevention Society Guideline-2017.pdf prepared by the Jordanian Osteoporosis Prevention Society (JOPS) 
*guidelines are to be submitted to a scientific publication, reference to follow

SaveSave